Christoph Franz

Christoph Franz ( born 2 May 1960 in Frankfurt am Main ) is a German manager. He has since January 1, 2011 CEO of Deutsche Lufthansa AG (until the end of May 2014) and since March 2014 Chairman of the Board of the Swiss pharmaceutical company Roche.

Life

Franz studied at the Technical University of Darmstadt Industrial Engineering and graduated as a Doctor of Economic and Social Sciences ( Dr. rer. Pol. ) From. In 1990 he entered the service of Deutsche Lufthansa, where he developed projects for strategy, sales and controlling. He worked from 1992 to 1994 on the staff of then CEO Jürgen Weber.

In 1994, Franz Deutsche Bahn AG. On September 24, 1999, he was, with effect from October 1, 1999, Travel & Tourism appointed by the Supervisory Board of Deutsche Bahn AG Chief Executive Officer of DB. He solved Axel Nawrocki In this function. At the same time he was thus a member of the Group Management Board of Deutsche Bahn AG. Previously, Franz was Director of Corporate Development. After the failure of the new pricing system, for which he had fought decisively, he was delivered to the Supervisory Board meeting of 20 May 2003 from his duties. He will be succeeded in his role Karl -Friedrich Rausch was appointed. The German railway cited the reason for the replacement of different views about how the difficulty of the price system could be resolved.

Franz was appointed by the Board of Directors of Swiss International Air Lines Chief Executive Officer ( CEO) on July 1, 2004. After successful restoration of the Swiss Franz was appointed Deputy Group Executive Board as of May 2009. He took over in June 2009 the passenger area. On 1 January 2011 he joined the Office of the Chief Executive Officer of Lufthansa as a successor to Wolfgang Mayr Huber at the Lufthansa on an ongoing profit rate to bring. During his tenure he has established the austerity program score with which the operating result is expected to be improved by € 1.5 billion from 2015.

Franz announced on September 16, 2013 announced that he would not for an extension of his period ending on 31 May 2014 contract available. The Swiss pharmaceutical company Hoffmann -La Roche announced on the same day that the Board of Directors will propose to the General Assembly on March 4, 2014 Franz as the new Chairman of the Board, in succession to Franz B. Humer. In support of that he would not renew his expiring in May 2014 director's contract with Deutsche Lufthansa AG, Franz stated that fascinates him in particular to be able to tackle a new challenge at Roche again.

Private

Franz is married and the father of five children.